Tech Company Financing Transactions
Nanostics Funding Round
On 6/26/2025, Nanostics received funding from Genome British Columbia.
Transaction Overview
Company Name
Announced On
6/26/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
This pivotal funding will further support the adoption of ClarityDX Prostate into the standard of care for prostate cancer screening, first in Alberta, then across Canada.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
10150 102 Street
Edmonton, AB, T5J 4C7
Canada
Edmonton, AB, T5J 4C7
Canada
Phone
Website
Email Address
Overview
Nanostics is a medical device and biotechnology company with a mission to provide clarity to people about their health by enabling better diagnosis and improving health care decisions through machine learning and extracellular vesicle detection.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Lewis
Chief Marketing Officer
Colin Coros
Chief Medical Officer
Adrian Fairey
Chief Medical Officer
Eric Hyndman
Chief Operating Officer
Catalina Vasquez
Chief Scientific Officer
Desmond Pink
Chief Technical Officer
Robert Paproski
Browse more venture capital transactions:
Prev: 6/26/2025: Waypoint AI venture capital transaction
Next: 6/26/2025: Enfinity Global venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC investment data records reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs